SETD2 and metabolic dysfunction-associated steatotic liver disease: A paradigm where HIF-1 and HIF-2 may function differently in connection to chronic liver disease (CLD) development is beginning to emerge from preclinical and clinical investigations, with a current emphasis mostly on progressing NAFLD and alcoholic liver disease (ALD) (Foglia et al., 2021).